# A Study in Patients With Rheumatoid Arthritis

> **NCT00966875** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 448 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** LY2439821
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00966875
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2011-03
- **Final completion:** 2012-06
- **Target enrollment:** 448 (ACTUAL)
- **Last updated:** 2016-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00966875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00966875, "A Study in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00966875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*